文献速递关节外科创伤骨科

静脉万古霉素预防给药不完整在初次全髋和膝关节置换术后常见且与感染并发症增加相关

Incomplete Administration of Intravenous Vancomycin Prophylaxis is Common and Associated With Increased Infectious Complications After Primary Total Hip and Knee Arthroplasty.
PubMed 文献 · J Arthroplasty · 2021-03-18

本研究回顾2013至2020年间1047例以静脉万古霉素作为主要围手术期革兰阳性菌预防用药的初次全髋或全膝关节置换患者,以切皮或止血带充气前30分钟为界定义给药是否充分。结果显示49.6%的患者给药不完整,该组因感染原因再入院率和确诊假体周围关节感染率均显著更高,回归分析确认输注不足30分钟是PJI的独立危险因素。

要点

  • 近半数初次全髋/膝关节置换患者万古霉素输注开始过晚(切皮前不足30分钟)。
  • 输注不足30分钟与因感染再入院率(3.6% vs 1.3%)和PJI率(2.2% vs 0.6%)显著升高相关。
  • 控制合并症后,万古霉素输注不足30分钟是PJI的独立危险因素(OR 5.22)。

核心结论

  • 万古霉素输注开始过晚在初次全髋和全膝关节置换患者中常见,并与因感染原因再入院率和假体周围关节感染率增加相关。
  • 术前应建立流程以确保有指征时万古霉素得到适当给药。

研究设计与样本

  • 回顾性队列研究,纳入2013至2020年间单中心1047例初次全髋或全膝关节置换患者(524例THA,523例TKA),均接受静脉万古霉素作为主要围手术期革兰阳性菌预防用药。
  • 以切皮或止血带充气前输注时间≥30分钟定义为给药适当(A组),<30分钟为给药不完整(B组),比较两组手术因素和质量结局。

主要发现

  • 静脉万古霉素使用指征为过敏(61%)、耐甲氧西林金黄色葡萄球菌定植(17%)、过敏合并定植(14%)和其他(8%)。
  • 50.4%的患者在术前>30分钟开始输注(A组),49.6%在术前<30分钟开始输注(B组)。
  • B组因感染原因再入院率显著高于A组(3.6% vs 1.3%,P = .017)。
  • B组确诊假体周围关节感染率显著高于A组(2.2% vs 0.6%,P = .023)。
  • 回归分析控制合并症后,万古霉素输注<30分钟是PJI的独立危险因素(OR 5.22,P = .012)。

关键数值与推荐

  • 以切皮或止血带充气前30分钟为界定义万古霉素给药是否充分:≥30分钟为适当,<30分钟为不完整。
  • B组因感染原因再入院率3.6% vs A组1.3%(P = .017)。
  • B组确诊PJI率2.2% vs A组0.6%(P = .023)。
  • 万古霉素输注<30分钟与PJI的独立关联OR 5.22(P = .012)。

临床怎么用

  • 对有万古霉素预防指征的初次全髋和全膝关节置换患者,应建立术前流程确保在切皮或止血带充气前至少30分钟开始输注。
  • 麻醉和手术团队应协调安排万古霉素输注起始时间,避免因输注过晚导致预防不完整。

局限性

  • 本研究为单中心回顾性研究,结果可能受机构实践模式影响。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vancomycin is often used as antimicrobial prophylaxis in patients undergoing total hip or knee arthroplasty. Vancomycin requires longer infusion times to avoid associated side effects. We hypothesized that vancomycin infusion is often started too late and that delayed infusion may predispose patients to increased rates of surgical site infections and prosthetic joint infections. METHODS: We reviewed clinical data for all primary total hip arthroplasty (THA) and total knee arthroplasty (TKA) patients at our institution between 2013 and 2020 who received intravenous vancomycin as primary perioperative gram-positive antibiotic prophylaxis. We calculated duration of infusion before incision or tourniquet inflation, with a cutoff of 30 minutes defining adequate administration. Patients were divided into two groups: 1) appropriate administration and 2) incomplete administration. Surgical factors and quality outcomes were compared between groups. RESULTS: We reviewed 1047 primary THA and TKA patients (524 THAs and 523 TKAs). The indication for intravenous vancomycin usage was allergy (61%), methicillin-resistant staphylococcus aureus colonization (17%), both allergy and colonization (14%), and other (8%). 50.4% of patients began infusion >30 minutes preoperatively (group A), and 49.6% began infusion <30 minutes preoperatively (group B). Group B had significantly higher rates of readmissions for infectious causes (3.6 vs 1.3%, P = .017). This included a statistically significant increase in confirmed prosthetic joint infections (2.2% vs 0.6%, P = .023). Regression analysis confirmed <30 minutes of vancomycin infusion as an independent risk factor for PJI when controlling for comorbidities (OR 5.22, P = .012). CONCLUSION: Late infusion of vancomycin is common and associated with increased rates of infectious causes for readmission and PJI. Preoperative protocols should be created to ensure appropriate vancomycin administration when indicated.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Feder OI, Yeroushalmi D, Lin CC, et al. Incomplete Administration of Intravenous Vancomycin Prophylaxis is Common and Associated With Increased Infectious Complications After Primary Total Hip and Knee Arthroplasty. J Arthroplasty. 2021. PMID: 33840539. doi:10.1016/j.arth.2021.03.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。